Health
SARS-CoV-2 replicon for high-throughput antiviral screening – DocWire News
J Gen Virol. 2021 May;102(5). doi: 10.1099/jgv.0.001583.ABSTRACTThe severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) virus, which is highly
J Gen Virol. 2021 May;102(5). doi: 10.1099/jgv.0.001583.
ABSTRACT
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) virus, which is highly pathogenic and classified as a biosafety level 3 (BSL-3) agent, has greatly threatened global health and efficacious antivirals are urgently needed. The high requirement of facilities to manipulate the live virus has limited the development of antiviral study. Here, we constructed a reporter replicon of SARS-CoV-2, which can be handled in a BSL-2…
-
Noosa News21 hours agoWoman was watching keepers work when lion attacked, Darling Downs Zoo says
-
Noosa News20 hours agoWorking for someone else made it hard to care for my daughter. So I quit
-
Noosa News23 hours agoStar Entertainment faces $36.5m blow if Queen’s Wharf deal flops
-
Business7 hours agoFord CEO makes stunning prediction about artificial intelligence